or Try an Advanced Search...

    ETF Components for IBRN - iShares Neuroscience and Healthcare ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    BHVN B 2.25 5.11
    PTCT B 1.38 4.73
    XENE C 1.41 3.92
    CPRX A 0.41 3.89
    ITCI A 2.11 3.71
    SRPT D -2.15 3.69
    AXNX A 0.10 3.68
    ALKS F 3.00 3.60
    EWTX B 1.28 3.59
    LBPH A -0.05 3.54
    NBIX C 1.61 3.46
    DYN F -0.42 3.39
    SRRK B -0.07 3.37
    BIIB F -0.12 3.30
    ACAD F 1.51 3.25
    SUPN B -0.29 3.17
    IART C 2.77 2.18
    AVDL C -2.71 2.09
    PRAX B -2.37 2.05
    SAVA D 1.57 2.05
    PRTA F -2.06 1.34
    CAPR B -3.23 1.12
    ANNX B -0.55 1.11
    DNTH A 0.54 1.00
    AXGN B -0.36 0.98
    NGNE B 4.68 0.88
    RAPP B 0.37 0.79
    AVXL A 3.25 0.78
    ZVRA A 3.07 0.73
    TRDA A 2.68 0.64
    ALEC D 2.03 0.62
    TSHA F -9.47 0.55
    CLPT A 4.04 0.54
    SGMO A 10.59 0.53
    LRMR C -5.90 0.53
    VYGR C 2.49 0.53
    ABEO B -2.50 0.44
    VNDA D 0.22 0.44
    CTNM D -0.66 0.41
    PEPG F -2.11 0.38
    AMLX B 4.44 0.36
    SLDB F 4.17 0.33
    NVRO D 0.36 0.30
    ABOS C -1.22 0.22
    ANRO F 2.31 0.16

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Neuroscience Alzheimer's Disease Biology Life Sciences Medicine Pain Rare Diseases Muscular Dystrophy Schizophrenia Central Nervous System Disorders Chemical Compounds Disease Dystrophy Epilepsy Gene Therapy Amyotrophic Lateral Sclerosis Cancer Depression
    Industries: Biotechnology Medical Devices Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major

    Recent News for iShares Neuroscience and Healthcare ETF & its Holdings

    Date Stock Title
    Nov 2 ITCI Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
    Nov 1 VNDA Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
    Nov 1 AVDL US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle
    Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 1 BIIB Biogen partner Eisai completes FDA submissions for injectable Alzheimer’s therapy
    Nov 1 AVDL Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term
    Nov 1 PRAX Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
    Nov 1 SRRK Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
    Nov 1 ALEC Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains?
    Nov 1 SGMO individual investors who own 55% along with institutions invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) saw increase in their holdings value last week
    Nov 1 BIIB Biogen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 1 PTCT Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
    Oct 31 BIIB Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
    Oct 31 VNDA Vanda started at buy by H.C. Wainwright, negative enterprise value cited
    Oct 31 SUPN Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024
    Oct 31 CLPT ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
    Oct 31 ACAD ACADIA Pharmaceuticals Inc (ACAD): Worst-Performing Growth Stock in 2024
    Oct 31 VNDA Health Care Roundup: Market Talk
    Oct 31 CLPT ClearPoint Neuro: Investors Enamored With Its Growth Prospects
    Oct 31 BIIB Biogen down as Morgan Stanley cuts rating on sluggish Alzheimer’s drug launch
    iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.
    Exchange Traded Funds Biopharmaceutical Ishares Blackrock Neuroscience
    Back to the Main IBRN Page...